Meloxicam/Rizatriptan

美洛昔康/利扎曲普坦

Report date: 2025/02/11 16:55:00

Base Information

Drug NameMeloxicam/Rizatriptan
Drug Alias Name苯甲酸利扎曲普坦/美洛昔康Rizatriptan Benzoate/Meloxicam苯甲酸利扎曲普坦+美洛昔康meloxicam + rizatriptan美洛昔康+利扎曲普坦 +[11] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor agonistsSerotonin 1d (5-HT1d) receptor agonistsCyclooxygenase-2 inhibitors +[4] 
TargetsCyclooxygenase-2Serotonin 1d (5-HT1d) receptorSerotonin 1b (5-HT1b) receptor +[4] 
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/01/30
Country/TerritoryUnited States
CombinationsYes Rizatriptan BenzoateMeloxicam
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAxsome Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAxsome Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG